Related Experiment Video
Updated: Sep 21, 2026

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
Rechallenge after Clozapine-Induced Neutropenic Events: A Case Series
Sumeet Gupta1, Mohamed Ismail2, Aysha Zabin3
1Gupta, MD, Psychiatry, Consultant Psychiatrist/Honorary Senior Lecturer, TEWV NHS Foundation Trust/York University, Darlington, England, United Kingdom. ORCID ID: 0000-0003-1586-5069.
Abstract:
Clozapine is highly effective for resistant schizophrenia but limited by neutropenia concerns. In this 30-year series, 27 patients discontinued clozapine and 13 were rechallenged; 61.5% were successfully maintained. No fatalities occurred, and index-episode severity did not predict outcomes. Rechallenge appears safe when guided by individualised risk-benefit assessment.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pyelonephritis I: Introduction
Hypersensitivity Reactions: Cytolytic Reactions
Chronic Pancreatitis II: Collaborative Care
Assessment:
Nephrotic Syndrome III : Nursing Management